Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

10% owner at NATR; 10% owner at CONTRAFECT Corp

Sold, on record
$1.4M
Dollars the filings state
Form 4 sales
3
Latest Oct 15, 2024
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale CONTRAFECT CorpPlan not stated
    Dec 4, 2018 2018

    Sold 600,000 shares at $2.04 ($1.2M)

    Shanghai Fosun Pharmaceutical (Group) Co., Ltd., 10% owner

    Sold 7.1% of holdings ($17.3M position)7.9M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale NATRNo plan
    Oct 14, 2024 +2141 days

    Sold 10,895 shares at $13.33 ($145k)

    Shanghai Fosun Pharmaceutical (Group) Co., Ltd., 10% owner

    No 10b5-1 planSold 14.1% of holdings ($1M position)66,467 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale NATRNo plan
    Oct 15, 2024 +1 day

    Sold 2,300 shares at $13.02 ($30k)

    Shanghai Fosun Pharmaceutical (Group) Co., Ltd., 10% owner

    No 10b5-1 planSold 3.5% of holdings ($865k position)64,167 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Source
Oct 15, 2024Oct 17, 2024NATR10% ownerForm 4 sale2,300$30k3.5%No planSEC
Oct 14, 2024Oct 15, 2024NATR10% ownerForm 4 sale10,895$145k14.1%No planSEC
Dec 4, 2018Dec 6, 2018CONTRAFECT Corp10% ownerForm 4 sale600,000$1.2M7.1%Plan not statedSEC